164.76
Schlusskurs vom Vortag:
$168.19
Offen:
$167.5
24-Stunden-Volumen:
160.96K
Relative Volume:
0.13
Marktkapitalisierung:
$20.65B
Einnahmen:
$1.53B
Nettoeinkommen (Verlust:
$-214.69M
KGV:
-93.62
EPS:
-1.76
Netto-Cashflow:
$-43.68M
1W Leistung:
-4.83%
1M Leistung:
-1.45%
6M Leistung:
+35.37%
1J Leistung:
+136.56%
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Vergleichen Sie NTRA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
NTRA
Natera Inc
|
164.68 | 20.65B | 1.53B | -214.69M | -43.68M | -1.76 |
![]()
TMO
Thermo Fisher Scientific Inc
|
536.57 | 205.72B | 42.88B | 6.34B | 7.27B | 16.53 |
![]()
DHR
Danaher Corp
|
211.64 | 149.54B | 23.88B | 3.90B | 5.30B | 5.28 |
![]()
A
Agilent Technologies Inc
|
135.86 | 39.02B | 6.51B | 1.29B | 1.37B | 4.42 |
![]()
IDXX
Idexx Laboratories Inc
|
458.19 | 37.08B | 3.90B | 887.87M | 808.08M | 10.67 |
![]()
IQV
Iqvia Holdings Inc
|
193.96 | 34.17B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-23 | Eingeleitet | Barclays | Overweight |
2024-06-03 | Fortgesetzt | Jefferies | Buy |
2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
2023-12-29 | Bestätigt | BTIG Research | Buy |
2023-12-14 | Eingeleitet | Guggenheim | Buy |
2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
2023-05-05 | Eingeleitet | UBS | Buy |
2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
2022-04-25 | Eingeleitet | Stephens | Overweight |
2022-03-08 | Eingeleitet | Goldman | Buy |
2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
2021-10-15 | Fortgesetzt | Cowen | Outperform |
2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
2021-01-28 | Eingeleitet | Truist | Buy |
2020-10-08 | Eingeleitet | BTIG Research | Buy |
2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
2018-10-05 | Eingeleitet | JP Morgan | Neutral |
2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
2016-11-10 | Bestätigt | The Benchmark Company | Buy |
2016-05-23 | Bestätigt | The Benchmark Company | Buy |
2016-05-11 | Bestätigt | The Benchmark Company | Buy |
2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Rhumbline Advisers Sells 1,620 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Vontobel Holding Ltd. Lowers Stake in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Natera (NTRA) to Release Earnings on Wednesday - MarketBeat
Is Gilead Sciences (GILD) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Alberta Investment Management Corp Sells 5,011,459 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Bought by Van ECK Associates Corp - MarketBeat
Natera (NTRA) Surged on Blowout Quarterly Results - Insider Monkey
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Principal Financial Group Inc. - MarketBeat
Chevy Chase Trust Holdings LLC Boosts Stock Position in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Banque Pictet & Cie SA Decreases Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025 - Business Wire
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Kornitzer Capital Management Inc. KS - MarketBeat
Natera (NTRA) Recently Broke Out Above the 20-Day Moving Average - MSN
Quent Capital LLC Sells 3,008 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today - Benzinga
Natera CEO Steven Chapman sells $12.96m in stock - MSN
Natera CFO Michael Burkes sells $4.28m in stock - MSN
Natera's chief legal officer sells $3.64 million in stock - MSN
11,294 Shares in Natera, Inc. (NASDAQ:NTRA) Bought by Guided Capital Wealth Management LLC - MarketBeat
Allspring Global Investments Holdings LLC Sells 115,810 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Stock Holdings Lowered by abrdn plc - MarketBeat
Empowered Funds LLC Decreases Stock Holdings in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera stock holds at $175 target, Raymond James sees progress - MSN
Sumitomo Mitsui Trust Group Inc. Purchases 69,455 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Canaccord maintains $180 target on Natera stock post-NCCN update - MSN
Mirae Asset Global Investments Co. Ltd. Sells 42,869 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Lecap Asset Management Ltd. Sells 3,150 Shares of Natera, Inc. (NASDAQ:NTRA) - MarketBeat
John Fesko Sells 663 Shares of Natera, Inc. (NASDAQ:NTRA) Stock - MarketBeat
Trade Tracker: Amy Raskin trims Vertex, Natera & Kadant, buys CareDx and Impinj - CNBC
October 17th Options Now Available For Natera (NTRA) - Nasdaq
Natera, Inc. Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Marketscreener.com
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection - StockTitan
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma - Yahoo Finance
Chicago Partners Investment Group LLC Invests $297,000 in Natera, Inc. (NASDAQ:NTRA) - MarketBeat
Natera president sells $290,120 in common stock - MSN
Natera, Inc. (NASDAQ:NTRA) CFO Sells $7,694,633.76 in Stock - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Shares Sold by Calamos Advisors LLC - MarketBeat
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):